ALLMedicine™ Kaposiform Hemangioendothelioma Center

Apr 17th, 2022 - Rapamycin has been recommended to treat Kaposiform hemangioendothelioma (KHE) with Kasabach-Merritt phenomenon (KMP), but the underlying mechanism of the clinical effect has not been established. Therefore, we determined rapamycin cytotoxicity on ...

Apr 15th, 2022 - To investigate the pretreatment differentiation between Kaposiform hemangioendothelioma (KHE) and fibro-adipose vascular anomaly (FAVA) in extremities of pediatric patients. To build and validate an MRI-based radiomic model. In this retrospective ...

Feb 10th, 2022 - Bone kaposiform hemangioendothelioma: A rare entity dramatically improved by sirolimus.|2022|Boccara O,Dangien A,Fitoussi F,Ducou Le Pointe H,Coulomb L'Hermine A,|

Jan 15th, 2022 - The Kasabach-Merritt phenomenon (KMP) in kaposiform hemangioendothelioma (KHE) is characterized by life-threatening thrombocytopenia and consumptive coagulopathy. This study compared the efficacy and safety of sirolimus plus prednisolone vs siroli...

Jan 14th, 2022 - Kaposiform Hemangioendothelioma of Internal Auditory Canal Presenting in 4-Week-Old Newborn.|2022|Colasacco CJ,Stidham K,Graifman G,Dominguez JF,Zeller S,|diagnostic imaging,surgery,diagnosis,diagnosis,

Jan 4th, 2022 - Kaposiform hemangioendothelioma (KHE) and tufted angiomas (TA) are rare vascular tumors, which are apparent predominantly in infancy or early childhood. Currently, no standard treatment regimens exist for KHE/TA. The aim of this study was to evalu...

Jan 27th, 2010 - History and Clinical Presentation A 7-week-old white infant girl presented to pediatric dermatology with a large facial hemangioma. The mother first noticed redness on the infant's left upper forehead at 2-3 days of age, and the lesion has been gr...